Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Positron Corporation Cites Espicom Business Intelligence Report that states molecular imaging market valued at $5 billion

Positron Corporation. The molecular imaging market is currently valued at approximately $5 billion, with half of the revenue being generated in North America alone, according to a market research report from Espicom Business Intelligence.

The outlook for the use of PET products is far more positive, according to the market analysis. Not only has there been an increase in the number of PET procedures being undertaken due to the lack of SPECT radiopharmaceutical availability, demand for PET is also rising as a result of the CMS decision in 2009 to expand reimbursement coverage for the use of FDG-PET in several new cancers, and to increase reimbursement rates for cardiac myocardial perfusion PET imaging by 20 percent.

Despite some short-term factors that are likely to impact growth in the MI market, there are strong opportunities in this area. The increasing incidence of cancer, cardiovascular and neurological diseases means that demand for faster and more accurate diagnosis, as well as drug development and pre-clinical study efforts, will continue to accelerate in the coming years, the report predicted.

Source: Positron